Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:276419.
doi: 10.1155/2011/276419. Epub 2011 May 18.

The metabolic syndrome and mind-body therapies: a systematic review

Joel G Anderson  1 , Ann Gill Taylor
Affiliations

The metabolic syndrome and mind-body therapies: a systematic review

Joel G Anderson et al. J Nutr Metab. 2011.

Abstract

The metabolic syndrome, affecting a substantial and increasing percentage of the worldwide population, is comprised of a cluster of symptoms associated with increased risk of type 2 diabetes, cardiovascular disease, and other chronic conditions. Mind-body modalities based on Eastern philosophy, such as yoga, tai chi, qigong, and meditation, have become increasingly popular worldwide. These complementary therapies have many reported benefits for improving symptoms and physiological measures associated with the metabolic syndrome. However, clinical trial data concerning the effectiveness of these practices on the syndrome as a whole have not been evaluated using a systematic and synthesizing approach. A systematic review was conducted to critically evaluate the data from clinical trials examining the efficacy of mind-body therapies as supportive care modalities for management of the metabolic syndrome. Three clinical trials addressing the use of mind-body therapies for management of the metabolic syndrome were identified. Findings from the studies reviewed support the potential clinical effectiveness of mind-body practices in improving indices of the metabolic syndrome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagram of review process and trial selection.
See this image and copyright information in PMC

References

    1. World Health Organization. Prevalence of Diabetes Worldwide. Vol. 2011. Lyon, France: World Health Organization; 2011.
    1. Seidell JC. Obesity, insulin resistance and diabetes—a worldwide epidemic. British Journal of Nutrition. 2000;83(supplement 1):S5–S8. - PubMed
    1. Ford ES, Li C, Zhao G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. Journal of Diabetes. 2010;2(3):180–193. - PubMed
    1. Rizvi AA. Type 2 diabetes: epidemiologic trends, evolving pathogenetic concepts, and recent changes in therapeutic approach. Southern Medical Journal. 2004;97(11):1079–1087. - PubMed
    1. Perry HM., III The endocrinology of aging. Clinical Chemistry. 1999;45(8):1369–1376. - PubMed

LinkOut - more resources